Adding a Lower Cutoff Value for CA19-9 May Identify Additional High-risk Cases of Pancreatic Cancer
CA19-9 is a biomarker whose levels often correlate with pancreatic cancer stage and prognosis PHILADELPHIA – A dual-threshold model...
CA19-9 is a biomarker whose levels often correlate with pancreatic cancer stage and prognosis PHILADELPHIA – A dual-threshold model...
PHILADELPHIA – The American Association for Cancer Research (AACR) today thanked Emerging Frontiers in Oncology (EFO) for its support...
SAN DIEGO – Patients who developed myocarditis within the first month of receiving immune checkpoint inhibitor therapy were more...
The treatment preserved quality of life SAN DIEGO – Injecting nivolumab (Opdivo) directly into precancerous oral lesions led to...
SAN DIEGO – Exposure to wildfire smoke was associated with a significantly increased risk of lung, colorectal, breast, bladder,...
Keith T. Flaherty, MD, FAACR, begins term as AACR President SAN DIEGO – The members of the American Association...
PHILADELPHIA – The American Association for Cancer Research (AACR) is proud to announce its newest class of grant recipients. Since 1993, the AACR...
SAN DIEGO – Between 2020 and 2024, the number of unique sites in the United States where phase I clinical trials for non-small cell lung cancer (NSCLC) were conducted decreased by 44% and became increasingly...
All patients were negative for minimal residual disease, and no patients experienced progression to active multiple myeloma during the...
This approach may eventually help guide personalized treatment decisions for patients diagnosed with these cancers SAN DIEGO – A...